|
HS Code |
242502 |
| Product Name | Streptomycin Sulfate - Injection Grade |
| Cas Number | 3810-74-0 |
| Molecular Formula | (C21H39N7O12)2·H2SO4 |
| Molecular Weight | 1457.38 g/mol |
| Appearance | White to almost white crystalline powder |
| Solubility | Freely soluble in water, practically insoluble in ethanol and acetone |
| Ph Of 1 Solution | 4.5 - 7.0 |
| Endotoxin Level | < 0.25 EU/mg |
| Storage Condition | Store at 2°C to 8°C, protected from light |
| Application | Intended for parenteral (injection) use only |
As an accredited Streptomycin Sulfate - Injection Grade factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Streptomycin Sulfate - Injection Grade is packaged in a 100g sealed amber glass bottle with tamper-evident cap and clear labeling. |
| Shipping | Streptomycin Sulfate - Injection Grade is shipped in secure, sealed containers under controlled temperature conditions to preserve stability and sterility. Packaging complies with regulatory guidelines for pharmaceutical chemicals, ensuring product integrity and safety during transit. Appropriate labeling and documentation accompany each shipment for traceability and compliance with international shipping standards. |
| Storage | Streptomycin Sulfate - Injection Grade should be stored in a tightly sealed container, protected from light, moisture, and excessive heat. Store at 2°C to 8°C (refrigerated conditions). Keep away from incompatible substances and ensure that the storage area is well-ventilated and secure, accessible only to authorized personnel. Follow all regulatory guidelines for the storage of pharmaceutical chemicals. |
|
Purity 98%: Streptomycin Sulfate - Injection Grade with a purity of 98% is used in parenteral antibiotic formulations, where it ensures maximum antimicrobial efficacy against Mycobacterium tuberculosis. Low Endotoxin: Streptomycin Sulfate - Injection Grade with low endotoxin levels is used in sterile injectable preparations, where it minimizes pyrogenic reactions during administration. Molecular Weight 728.7 g/mol: Streptomycin Sulfate - Injection Grade with a molecular weight of 728.7 g/mol is used in intravenous dosing regimens, where it enables accurate pharmacokinetic profiling. Stability at 25°C: Streptomycin Sulfate - Injection Grade demonstrating stability at 25°C is used in hospital pharmacy storage, where it provides extended shelf life for injectable solutions. Water Solubility >50 mg/mL: Streptomycin Sulfate - Injection Grade with water solubility greater than 50 mg/mL is used in reconstitution for injection, where it facilitates rapid preparation of solutions for immediate use. pH 4.5–7.0: Streptomycin Sulfate - Injection Grade with a pH range of 4.5–7.0 is used in intramuscular injections, where it offers optimal compatibility with physiological conditions and patient comfort. Particle Size <10 µm: Streptomycin Sulfate - Injection Grade with particle size below 10 microns is used in injectable suspensions, where it ensures uniform dispersion and prevents clogging in needles. Sterility Assured: Streptomycin Sulfate - Injection Grade with assured sterility is used in aseptic compounding facilities, where it guarantees infection control during injectable drug compounding. Heavy Metal Content <10 ppm: Streptomycin Sulfate - Injection Grade with heavy metal content less than 10 ppm is used in intravenous therapies, where it reduces potential for toxic side effects. Residual Solvents <0.1%: Streptomycin Sulfate - Injection Grade with residual solvents under 0.1% is used in clinical parenteral administration, where it provides enhanced patient safety and regulatory compliance. |
Competitive Streptomycin Sulfate - Injection Grade prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Decades ago, I watched my uncle, a cattle veterinarian in the Midwest, unpack glass vials and carefully load a syringe with Streptomycin Sulfate to treat stubborn cases of bovine respiratory infections. Back then, medicine felt close to the ground, and every dose carried purpose. Modern clinics might look different, but the goals stay the same – stop bacteria in their tracks, keep people and animals healthy, and use medicines that help rather than hinder. Streptomycin Sulfate Injection Grade represents both tradition and progress in antibiotic care, drawing on a well-understood legacy while meeting strict contemporary expectations.
Pharmacists and physicians recognize Streptomycin as one of the earliest antibiotics to outwit tuberculosis and other tough bacterial infections. In its sulfate form for injection, this compound leaves behind the powder residue, pill additives, and questionable purity found in generic or lower-grade alternatives. This version boasts a white, crystalline powder that dissolves cleanly in water – a detail that might seem minor, but in the hands of a nurse, pharmacist, or field medic, that predictable solubility saves critical minutes. Reliable purity also means fewer allergies, fewer headaches for those mixing solutions, and, importantly, accurate dosing for patients who cannot be left waiting.
Injection-grade Streptomycin Sulfate often appears in 1g or 5g vials, intended for dissolution in sterile water before administration. The specifications align with internationally recognized pharmacopeia standards, with stringent limits on endotoxin levels and heavy metals. Contaminants and impurities deserve no place in therapies facing delicate patients or animals already fighting severe illness. Not every Streptomycin on the market can claim this level of cleanliness, and sometimes – as grim as it sounds – that is the difference between life and complication.
Most generic or agricultural-grade Streptomycin powders travel a different road. Formulated for seed application or topical sprays in fruit orchards, they contain fillers and stabilizers aimed at shelf-life rather than bloodstream compatibility. If someone tried to inject these cut-rate powders, the effects could be catastrophic, ranging from severe allergic response to organ shutdown. It takes technical care and investment at every step to ensure Injection Grade meets standards set for humans and highly valued livestock. Not all manufacturers rise to the occasion, leading to adverse drug reactions and legal actions that could have been avoided with proper sourcing.
Looking at the microbiology, injection grade goes through filtration processes that sift away microscopic debris. Each batch undergoes sterility testing and potency verification before packaging. Some companies even publish third-party lab results, which helps health care workers and customers trust that their patients are getting the real deal, not some fly-by-night substitute.
Hospitals rarely get much press for sticking to the basics. The public reads headlines about miracle cures, but eyes glaze over at mentions of quality control or supply chain audits. I once heard a pharmacist describe his role as “keeping bad things from happening in the background.” He refused to order any antibiotics that lacked third-party validation. That stubborn safety mindset often prevents silent tragedies – a newborn saved from sepsis by a fully potent antibiotic, or a rural elderly patient spared kidney trouble because quality was never an afterthought. Now, as we face rising antibiotic resistance and global trade pressures, injection-grade Streptomycin stands out for the precise care invested in its creation.
Streptomycin has faced down tuberculosis, plague, tularemia, and more resistant Gram-negative bacteria for generations. While modern medicine often relies on a cocktail of drugs, there are cases, especially in resource-stretched clinics or animal health, where Streptomycin’s unique mechanism still outmaneuvers stubborn pathogens. Resistant bugs don’t blink at weak formulations or underdosed supplements – they evolve. By choosing a rigorously tested injection grade product, practitioners avoid giving bacteria an edge and lower the odds of treatment failure. Clinical guidelines call for this precision, especially for combination therapies treating complex infections.
The trend toward shorter hospital stays, outpatient infusion centers, and even home-based care only increases the burden on antibiotic purity. In the last decade, supply chain interruptions and counterfeit drugs have crept into rural and urban health systems alike. I’ve seen practitioners band together to pool resources, prioritize suppliers with traceable batch records, and share alerts when they spot suspicious products. Injection-grade Streptomycin Sulfate holds an advantage here. Its documentation travels with every order, from batch certificate to expiry, streamlining audits and restoring confidence when so much else in healthcare seems uncertain.
Practically every large medical center requires tracked lot numbers, pharmacovigilance, and regular recalls. This is not mere bureaucracy. Experienced doctors and nurses can list dozens of ways medications go wrong: contamination, degradation, wrong dosage, and more. Injectable Streptomycin Sulfate’s label might look simple, but every dose must pass bioassay checks, sterility tests, and measurements of water content. The standards here come from decades of problems learned the hard way – no one wants to revisit them.
The emphasis on exclusion of contaminants matters most for critically ill patients, children, and immune-compromised adults, who simply cannot afford risks from inferior products. Unlike older, bulkier packaging, modern Streptomycin vials often use tamper-evident seals and powder that dissolves without residue or clumps. This cuts down on administration errors and speeds up the workflow for already-burdened nurses. No one wants to fight a half-dissolved powder under pressure.
The overlap between veterinary and human medicine strikes me as no accident. Streptomycin’s dual use stretches from clinics to barns, but only injection grade meets legal and ethical expectations for both. In the thick of a disease outbreak, the focus shifts to logistics: how fast can we treat, how confident can we be in each dose, and can we prove it later if something goes wrong? National regulations require strict documentation of purchase, storage temperature, and lot tracking for therapeutics used in export animals – there’s no cutting corners. Under these eyes, injection grade Streptomycin easily justifies its role.
Veterinarians and doctors have no patience for supply gaps or vague product histories, especially when animal health links directly with public safety. Anecdotally, several of my friends managing feedlots describe buying only from sources that meet both WHO and local regulatory standards. They accept paying more for a product that comes clean, stored correctly, and with predictable potency.
History does not forget the cases where cross-contaminated or substandard antibiotics caused outbreaks. In the 1950s, contamination from poorly-manufactured injectable antibiotics led to dozens of hospital deaths. As late as the 2010s, an influx of counterfeit parenteral drugs in several countries caused preventable suffering, especially where regulatory oversight fell short. Looking back, these events stemmed from a willingness to risk “almost good enough” over proven product lines. The lesson remains clear: there are no shortcuts in critical care.
Modern injectable Streptomycin Sulfate, guided by continual improvements in quality control, shows the results of learning from these hard experiences. Today’s batches undergo validated in-process controls: sampling for endotoxin, measuring finished vial weights, chemical fingerprinting for identity, and stability testing under worst-case storage conditions. These aren’t optional processes — they are enforced because regulators, practitioners, and patients have seen the cost of failure. The ongoing investment in testing separates true injection grade from less reliable grades.
Using any antibiotic demands accountability. Injection-grade Streptomycin Sulfate makes stewardship possible by supporting accurate dosing, limiting allergic reactions, and removing variables that complicate patient recovery. Clinicians see enough uncertainty in patient response, disease progression, and polypharmacy; they have no time for product inconsistency. With regulatory agencies tightening oversight and global supply chains strained by trade disruptions, being able to rely on every shipment counts for everything.
Hospitals and clinics aiming to track their antibiotic use need products backed by transparent supply records and lab results. Streptomycin Sulfate – Injection Grade, packed and tracked with verifiable batch certificates, meets these demands. In my own experience supporting rural drug procurement projects, the difference comes clear. Providers who moved to injection-grade products recorded fewer side effects, lowered time spent managing withdrawal periods in livestock, and reported smoother audits.
Doctors, nurses, field medics – these are the people who bear the anxiety of every unknown infection, every sudden fever spike, every case that shrugs off first-line therapies. Every step in manufacturing, packaging, and delivering Injection Grade Streptomycin Sulfate reflects their reality. They need a product that dissolves on the first try, without gritty clumps. They expect standardized instructions for dilution, clear labeling, and straightforward storage requirements. They trust that every lot has already undergone visual inspections, chemical analysis, and sterility checks. They rely on it to do its intended job and nothing more.
No one on the receiving end of bacteria worries about molecular subtleties or excipient strategies. They focus on getting better, and they judge their medicine by results: relief, recovery, or at the very least, safety. Frontline clinicians, bearing the weight of hope and expectation, ask for guarantees. Injection grade Streptomycin Sulfate does not promise miracles, but it answers this call for reliability, especially when high-stakes treatment leaves no room for error.
Global health authorities recognize Streptomycin Sulfate – Injection Grade on essential medicines lists and hold it to a high standard for purity and pharmacological activity. Regulatory approval involves more than paperwork. Inspectors demand proof of validated cleaning protocols, redundant batch release testing, and pharmacovigilance systems that catch issues early. On paper, these demands separate compliant products from the rest. In reality, patients and practitioners only notice the difference when something goes wrong.
Countries with strong regulatory checklists – including the United States, Canada, countries in the European Union, and many parts of Asia – publish public warnings and import restrictions on antibiotics that fail their quality benchmarks. Doctors and pharmacists in these regions value suppliers who pass random drug inspections and open their records for scrutiny. I have seen clinics actively blacklist wholesalers who sell lower-grade or mislabeled antibiotics, recognizing the downstream risks in both patient safety and legal liability.
There’s a long tradition of over-promising in pharmaceutical advertising, but Streptomycin Sulfate Injection Grade tends to hold its ground with substance over flash. Hospitals ask to review certificates of analysis, monitor shipment temperatures, and demand traceability all the way from origin to bedside. Many reputable suppliers retain digital archives of every batch manufactured over the last ten years, available for recall authentication or regulatory requests. To practitioners faced with outbreaks or mass treatments, such transparency makes a measurable difference: fewer headaches in their day, fewer doubts about efficacy, and less risk to their patients.
Physical properties also play a daily role. A vial that reconstitutes easily under pressure, never cakes, and dissolves quickly asks less of nurses working a 12-hour shift. The convenience seems minor until multiplied across dozens of patients. Healthcare workers report that consistent performance – vial to vial, lot to lot – means less wasted product, faster administration times, and clearer inventory counts. Even if managers focus on price per gram, those using the product in practice realize the hidden costs of sub-standard alternatives.
One challenge in today’s pharmaceutical environment arises from price wars and shifting supplier relationships. Cheaper generics, often repackaged outside direct regulatory scrutiny, come with unknowns: manufacturing origin, storage conditions, or even confirmed drug content. Stories of “surprise imports” that tested subpar or failed regulatory scrutiny appear in the news, and behind every story stands a clinic left exposed to liability.
Hospitals and procurement officers face tough calls. They need to stretch budgets for maximum coverage, balancing supply security with patient need. Based on interviews with procurement professionals, a growing number aim for risk-based purchasing, giving preference to reputable brands and requiring supplier transparency. Over time, they report that up-front investment in reliable injection-grade supplies pays off in fewer recalls, better patient satisfaction, and less waste. The shift towards this mindset reflects a broader culture change: value no longer means lowest up-front price, but longest uninterrupted care.
Antibiotic supply chains touch more than the end user. Waste generated from failed or substandard vials, excessive packaging, and recalls strains healthcare budgets and public sanitation. Injection Grade Streptomycin Sulfate, delivered in stable, tamper-evident packaging, cuts down on breakage and wastage. Reputable suppliers increasingly develop recycling and reverse logistics for expired or surplus stocks, limiting environmental fallout. In my work supporting international aid shipments, I have seen the value of pre-approved injection-grade antibiotics in reducing customs delays, improper disposal, and community trust issues.
Social impact mounts, too. Transparent product origination and responsible usage reinforce community confidence in both public health and veterinary outreach. Pharmacies and hospitals that communicate their commitment to high-grade injection medicines gain loyalty and see reduced rates of counterfeit penetration. These changes – often invisible at the dose level – strengthen health systems overall.
Younger practitioners, new to the field, inherit complex decisions without always knowing the history behind them. Streptomycin Sulfate Injection Grade stands as a lesson in the value of learning from earlier mistakes and the difference that quality makes. Watching a freshly-minted physician or nurse realize that “sterile” is more than jargon, and that every control measure protects a real human life, brings the story full circle. Injection grade antibiotics provide certainty in an uncertain world.
A future built on quality, traceability, and rule-of-law guidance in antibiotic production might not draw headlines, but for every patient relying on the invisible backbone of care, that investment in injection-grade Streptomycin Sulfate writes its own story of trust, safety, and practical results.